Table 3.

ROC curves of six lipid ratios for the diagnosis of NAFLD in patients with new-onset T2DM.

	AUC	95% CI	P-Values	Youden index	Cut-off point	Sensitivity	Specificity
TG/HDL-C	0.732	0.696-0.769	<0.001	0.339	1.405	0.738	0.601
TC/HDL-C	0.683	0.644-0.721	<0.001	0.289	5.175	0.575	0.714
FFA/HDL-C	0.652	0.612-0.692	<0.001	0.232	0.475	0.701	0.532
LDL-C/HDL-C	0.656	0.616-0.696	<0.001	0.245	3.485	0.569	0.675
UA/HDL-C	0.667	0.627-0.706	<0.001	0.275	360.2	0.514	0.761
APOB/APOA1	0.663	0.623-0.702	<0.001	0.280	0.945	0.573	0.767

NAFLD, non-alcoholic fatty liver disease; T2DM, type 2 diabetes mellitus; TG/HDL-C, triglycerides to high-density lipoprotein-cholesterol ratio; TC/HDL-C, cholesterol to HDL-C ratio; FFA/HDL-C, free fatty acid to HDL-C ratio; UA/HDL-C, uric acid to HDL-C (UA/HDL-C) ratio; LDL-C/HDL-C, low-density lipoprotein-cholesterol to HDL-C; APOB/A1, apolipoprotein B to apolipoprotein A1.